This document summarizes statistics on overweight and obesity rates among children and adults in the United States. Some key points:
- About 1 in 3 children ages 2-19 are overweight or obese, with rates highest among low-income households and some minority groups.
- Over 150 million adults are overweight or obese, with obesity rates highest among non-Hispanic black women and Mexican American men and women.
- Healthcare costs related to obesity could reach $861-957 billion annually by 2030, accounting for 16-18% of total US health expenditures.
As a chronic disease it is prevalent in both developed and developing countries, and affecting children(10-20%) as well as adults(20-40%).Excess weight gain invites many associated diseases.
As a chronic disease it is prevalent in both developed and developing countries, and affecting children(10-20%) as well as adults(20-40%).Excess weight gain invites many associated diseases.
The health hazards associated with obesity. Mortality morbidity
Complications related to obesity
type 2 diabetes.
high blood pressure.
heart disease and strokes.
certain types of cancer.
sleep apnea.
osteoarthritis.
fatty liver disease.
My seminar Obesity by Hani
Obesity is a public health and policy problem because of its increase prevalence, costs and health effect. (WHO, 2012, National heart lung and blood institute. 2012)
. The risk factor for chronic disease are highly prevalence (Zindah, Belbeisi, Walke & Makdad 2008)
The obesity and the overweight are risk for number of chronic disease include diabetes cardio vascular disease and cancer (WHO,2010)
Redefining urban: a new way to measure metropolitan areas. Functional Urban Areas in OECD countries. For more information on OECD's urban development work see www.oecd.org/regional/regional-policy/urbandevelopment.htm
The health hazards associated with obesity. Mortality morbidity
Complications related to obesity
type 2 diabetes.
high blood pressure.
heart disease and strokes.
certain types of cancer.
sleep apnea.
osteoarthritis.
fatty liver disease.
My seminar Obesity by Hani
Obesity is a public health and policy problem because of its increase prevalence, costs and health effect. (WHO, 2012, National heart lung and blood institute. 2012)
. The risk factor for chronic disease are highly prevalence (Zindah, Belbeisi, Walke & Makdad 2008)
The obesity and the overweight are risk for number of chronic disease include diabetes cardio vascular disease and cancer (WHO,2010)
Redefining urban: a new way to measure metropolitan areas. Functional Urban Areas in OECD countries. For more information on OECD's urban development work see www.oecd.org/regional/regional-policy/urbandevelopment.htm
Global Medical Cures™ | Overweight and Obesity Statistics (USA)
DISCLAIMER-
Global Medical Cures™ does not offer any medical advice, diagnosis, treatment or recommendations. Only your healthcare provider/physician can offer you information and recommendations for you to decide about your healthcare choices.
Obesity, Latinos, and Diet
Daniel Santibanez, MPH, University of North Florida
May 27. 2005 - UNF Hispanic Health Issues Seminar
This is part 4 of an 8 part series of seminars on Hispanic Health Issues brought to you by the University of North Florida’s Dept. of Public Health, College of Health, a grant from AETNA, and the cooperation of Duval County Health Department.
From the CDC why it is so important to wake up and be proactive before the reactive healthcare become a reality. Hospitalization, Doctors, Medicines are for the most part concerned with symptoms. We are excited to share a plan that works quickly, burns up belly fat and teaches new habits of eating moving forward that will lead you into a healthy, lean lifestyle so that you keep the fat off for the rest of your life!
TEN-STEP STUDY PLAN1. Statement of the problem and its significa.docxmehek4
TEN-STEP STUDY PLAN
1. Statement of the problem and its significance
2. Theoretical or conceptual framework
3. Research questions to be answered by the study
4. List of hypotheses to be tested
5. Definitions of key terms and variables
6. Description of the research design
7. Description of the sample and how it was obtained
8. Description of the planned statistical analysis
9. Statement of assumptions and limitations
10. Dissemination plan.
obesity pdf.pdf
NCHS Data Brief ■ No. 219 ■ November 2015
Prevalence of Obesity Among Adults and Youth:
United States, 2011–2014
Cynthia L. Ogden, Ph.D.; Margaret D. Carroll, M.S.P.H.; Cheryl D. Fryar, M.S.P.H.;
and Katherine M. Flegal, Ph.D.
Figure 1. Prevalence of obesity among adults aged 20 and over, by sex and age: United States,
2011–2014
P
er
ce
nt
0
10
20
30
40
50 60 and over40–5920–3920 and over
WomenMenAll
36.3
32.3
140.2
137.0
234.3
230.3
1,238.3
34.9
38.3
34.4
142.1
138.8
1Significantly different from those aged 20–39.
2
Key findings
Data from the National
Health and Nutrition
Examination Survey
● In 2011–2014, the
prevalence of obesity was just
over 36% in adults and 17% in
youth.
● The prevalence of obesity
was higher in women (38.3%)
than in men (34.3%). Among
all youth, no difference was
seen by sex.
● The prevalence of obesity
was higher among middle-aged
(40.2%) and older (37.0%)
adults than younger (32.3%)
adults.
● The prevalence of obesity
was higher among non-
Hispanic white, non-Hispanic
black, and Hispanic adults and
youth than among non-Hispanic
Asian adults and youth.
● From 1999 through 2014,
obesity prevalence increased
among adults and youth.
However, among youth,
prevalence did not change
from 2003–2004 through
2013–2014.
U.S. DEPA
Obesity is associated with health risks (1,2). Monitoring the prevalence
of obesity is relevant for public health programs that focus on reducing
or preventing obesity. No significant changes were seen in either adult or
childhood obesity prevalence in the United States between 2003–2004 and
2011–2012 (3). This report provides the most recent national data on obesity
prevalence by sex, age, and race and Hispanic origin, using data for 2011–
2014. Overall prevalence estimates from 1999–2000 through 2013–2014 are
also presented.
Keyword: National Health and Nutrition Examination Survey
What was the prevalence of obesity among adults in
2011–2014?
The prevalence of obesity was 36.5% (crude estimate) among U.S. adults
during 2011–2014. Overall, the prevalence of obesity among middle-aged
RTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
National Center for Health Statistics
Significantly different from women of the same age group.
NOTES: Totals were age-adjusted by the direct method to the 2000 U.S. census population using the age groups 20–39, 40–59,
and 60 and over. Crude estimates are 36.5% for all, 34.5% for men, and 38.5% for women.
SOURCE: CDC/NCHS, ...
nejm obesidad en adolescente. 2102062.pdfmedineumo
obesidad en adolescente: suscríbase a nuestro canal de YouTube _MediNeumo_
La obesidad durante la adolescencia (10 a 19 años de edad) está asociada con consecuencias para la salud que incluyen prediabetes y diabetes tipo 2, enfermedad del hígado graso no alcohólico, dislipidemia, síndrome de ovario poliquístico (SOP), apnea obstructiva del sueño, y salud mental trastornos y estigma social. demás, la obesidad durante la adolescencia es un factor de riesgo de complicaciones y muerte por enfermedad coronaria , así como de muerte por cualquier causa en la edad adulta, incluida la edad adulta temprana.
Similar to Overweight and Medical Condition in US : 3 Factors that affect Childhood obesity (20)
Catching up with shivakeshavan cii mumbai : Our Sumit Roy
Mallcom India Director Mr. Giriraj Mall on why Mallcom choose to sponsor Shiva Keshavan for 3 years apart from making a coffee table book on his life. Shiva Keshavan is the only Luge sportsperson from India to have participated in the Olympics 6 times. He holds the record for being the fastest Asian Luger (134.3km/hour and is accurately nicknamed the “Fastest Asian on Ice” At 16 he became the youngest Luger to participate in the winter Olympics.
research report on online food ordering market in IndiaSumit Roy
Indian online food delivery is set to boom according to the latest research report.The Restaurant industry is estimated to be USD 56 Billion and thedelivery industry is pegged atUSD 15 Billion
The Indian Casual Dining (44%) dominatesthe organised segment while QSR is one of the fastest growing
segment
how iOT is set to herald the Renaissance of 2nd industrial revolution Sumit Roy
Internet of things will all set to herald the second industrial revolution. From Industries as diverse as manufacturing, automotive,industrial, home electronics,Oil and Gas,Insurance including hardware and software,
patents received by the top 5 technology companies Sumit Roy
THE ‘BIG 5’ PATENTS REPORT
Patent activity and trends across Amazon, Apple, Facebook, Google,and Microsoft
OVERALL PATENT ACTIVITY FROM BIG 5 COHORT ON
THE RISE
Applications trend upwards: Collectively, these IP powerhouses
have applied for more than 52,000 patents since 2009. Total
applications have steadily risen as each company diversifies its
research activities, with annual combined applications nearing
10,000 in 2013.
Microsoft leads, Facebook lags: Microsoft has filed for the most
patents, applying for over 16,800 since 2009, with second-place
Google applying for more than 14,500. Apple was in 3rd and
Amazon 4th, with Facebook lagging significantly behind.
Grants also rising: Although somewhat dependent on the USPTO
approval process, annual grant publications for this cohort have
also consistently grown. Google is now surpassing Microsoft for
the top spot here in part thanks to the reversal of its anti-patent
stance early in the decade.
INDIVIDUAL PATENTS REVEAL BROAD INTERESTS IN AI,
AR/VR, AND VEHICLES
AI activity skyrockets: 2014 applications with AI-related keywords
have already set an annual record, with more applications likely to be published. Microsoft leads with Google quickly rising in second,
while Apple lags all of its peers thus far.
Facebook picking up: Although behind the other four in overall
filings, its activity is on the rise and recently published applications reveal its efforts to automate the removal of objectionable contentusing machine learning.
Apple targets vehicles, wearables: Apple came in second behind Google in our keyword analysis of vehicle-related tech. Individual filings point to research in autonomous vehicles and AR/VR.
Amazon broadens activities: The e-commerce company has
moved from consumer devices like e-book readers and tablets to drones, cybersecurity, and potentially tech to support its Go stores.
programmatic Buying in Mobile Advertising Sumit Roy
74% of marketers are now using programmatic media buying on mobile for retargeting users, 62% use it for performance marketing and 61% for branding. • This represents a huge opportunity for the industry to build targeting and measurement solutions that deliver greater effectiveness and efficiency for upper-funnel campaigns. Of those not using programmatic, the biggest barriers for adoption are complexity of the ecosystem (58%), skills shortage (42%) and lack of education (33%).
State of mobile mobile developers:ecosystem and marketing mixSumit Roy
InMobi undertook a survey of mobile developers across the world in an attempt to understand the ever growing
ecosystem better. The Mobile app developer survey from InMobi drawn from over 1000+ respondents across 155
countries showcases some insightful data on the latest trends in the mobile app ecosystem, including developer
mindshare, platform of choice , revenue models, challenges and motivations and mobile ad network preferences.
top 5 indicators on pharma brands and marketing spendsSumit Roy
pharma brands and how they plan to spend on marketing . This research data shows " pharma companies and which media channels they intend to spend online . Suprisisngly mobile channel remains the most " powerful and valuable channel" which pharma brands plans to spend on this year,followed by social and online.
2016 BrandZ™ Top 100 Most Valuable Global Brands increased 3 percent, to $3.4...Sumit Roy
In a year marked by disruption, the value of the 2016 BrandZ™ Top 100 Most Valuable Global Brands increased 3 percent, to $3.4 trillion.
Six of the 14 categories included in the 2016 ranking declined in value compared with only two last year. One category remained flat. Of the seven categories that increased in value, only two grew by more than 10 percent.
global Venture funding and start up data : top 10 chartsSumit Roy
2015 VC FUNDING HITS ALL-TIME HIGH. ENDS WITH PULLBACK.
Multi-year highs in funding: Globally, funding to VC-backed companies in 2015 hit an all-time high of $128.5B, up 44 percent versus 2014’s total of $89.4B.
Deals see steep decline: Large deals were the headline of 2015, largely driving the funding trends and leaving deal activity to fall for the final 2 quarters, including Q4’15, which saw just 1742 deals, the lowest quarterly total since Q1’13.
top 100 start up companies with valuations of 1$ billion and aboveSumit Roy
the list of start ups which are a unicorn ( valuation above 1 billion ISD) Each start ups is mapped to its business vertical, the country of origin and the vc investment by funds
global biggest start up companies with valuations of 1$ billion and aboveSumit Roy
CBI insights lists the top 100 the biggest Unicorns with $1billion and more in valuation. Investment of individual start ups, total valuation and the business verticals are also mapped .
Rapidly evolving urban consumer attitudes are transforming our world. With only 5 years to go until 2020, the future seems closer than ever.These are top 10 consumer products that would change consumers and their interaction with devices
Navigating the Health Insurance Market_ Understanding Trends and Options.pdfEnterprise Wired
From navigating policy options to staying informed about industry trends, this comprehensive guide explores everything you need to know about the health insurance market.
Telehealth Psychology Building Trust with Clients.pptxThe Harvest Clinic
Telehealth psychology is a digital approach that offers psychological services and mental health care to clients remotely, using technologies like video conferencing, phone calls, text messaging, and mobile apps for communication.
Defecation
Normal defecation begins with movement in the left colon, moving stool toward the anus. When stool reaches the rectum, the distention causes relaxation of the internal sphincter and an awareness of the need to defecate. At the time of defecation, the external sphincter relaxes, and abdominal muscles contract, increasing intrarectal pressure and forcing the stool out
The Valsalva maneuver exerts pressure to expel faeces through a voluntary contraction of the abdominal muscles while maintaining forced expiration against a closed airway. Patients with cardiovascular disease, glaucoma, increased intracranial pressure, or a new surgical wound are at greater risk for cardiac dysrhythmias and elevated blood pressure with the Valsalva maneuver and need to avoid straining to pass the stool.
Normal defecation is painless, resulting in passage of soft, formed stool
CONSTIPATION
Constipation is a symptom, not a disease. Improper diet, reduced fluid intake, lack of exercise, and certain medications can cause constipation. For example, patients receiving opiates for pain after surgery often require a stool softener or laxative to prevent constipation. The signs of constipation include infrequent bowel movements (less than every 3 days), difficulty passing stools, excessive straining, inability to defecate at will, and hard feaces
IMPACTION
Fecal impaction results from unrelieved constipation. It is a collection of hardened feces wedged in the rectum that a person cannot expel. In cases of severe impaction the mass extends up into the sigmoid colon.
DIARRHEA
Diarrhea is an increase in the number of stools and the passage of liquid, unformed feces. It is associated with disorders affecting digestion, absorption, and secretion in the GI tract. Intestinal contents pass through the small and large intestine too quickly to allow for the usual absorption of fluid and nutrients. Irritation within the colon results in increased mucus secretion. As a result, feces become watery, and the patient is unable to control the urge to defecate. Normally an anal bag is safe and effective in long-term treatment of patients with fecal incontinence at home, in hospice, or in the hospital. Fecal incontinence is expensive and a potentially dangerous condition in terms of contamination and risk of skin ulceration
HEMORRHOIDS
Hemorrhoids are dilated, engorged veins in the lining of the rectum. They are either external or internal.
FLATULENCE
As gas accumulates in the lumen of the intestines, the bowel wall stretches and distends (flatulence). It is a common cause of abdominal fullness, pain, and cramping. Normally intestinal gas escapes through the mouth (belching) or the anus (passing of flatus)
FECAL INCONTINENCE
Fecal incontinence is the inability to control passage of feces and gas from the anus. Incontinence harms a patient’s body image
PREPARATION AND GIVING OF LAXATIVESACCORDING TO POTTER AND PERRY,
An enema is the instillation of a solution into the rectum and sig
Antibiotic Stewardship by Anushri Srivastava.pptxAnushriSrivastav
Stewardship is the act of taking good care of something.
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
WHO launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015 to fill knowledge gaps and inform strategies at all levels.
ACCORDING TO apic.org,
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
ACCORDING TO pewtrusts.org,
Antibiotic stewardship refers to efforts in doctors’ offices, hospitals, long term care facilities, and other health care settings to ensure that antibiotics are used only when necessary and appropriate
According to WHO,
Antimicrobial stewardship is a systematic approach to educate and support health care professionals to follow evidence-based guidelines for prescribing and administering antimicrobials
In 1996, John McGowan and Dale Gerding first applied the term antimicrobial stewardship, where they suggested a causal association between antimicrobial agent use and resistance. They also focused on the urgency of large-scale controlled trials of antimicrobial-use regulation employing sophisticated epidemiologic methods, molecular typing, and precise resistance mechanism analysis.
Antimicrobial Stewardship(AMS) refers to the optimal selection, dosing, and duration of antimicrobial treatment resulting in the best clinical outcome with minimal side effects to the patients and minimal impact on subsequent resistance.
According to the 2019 report, in the US, more than 2.8 million antibiotic-resistant infections occur each year, and more than 35000 people die. In addition to this, it also mentioned that 223,900 cases of Clostridoides difficile occurred in 2017, of which 12800 people died. The report did not include viruses or parasites
VISION
Being proactive
Supporting optimal animal and human health
Exploring ways to reduce overall use of antimicrobials
Using the drugs that prevent and treat disease by killing microscopic organisms in a responsible way
GOAL
to prevent the generation and spread of antimicrobial resistance (AMR). Doing so will preserve the effectiveness of these drugs in animals and humans for years to come.
being to preserve human and animal health and the effectiveness of antimicrobial medications.
to implement a multidisciplinary approach in assembling a stewardship team to include an infectious disease physician, a clinical pharmacist with infectious diseases training, infection preventionist, and a close collaboration with the staff in the clinical microbiology laboratory
to prevent antimicrobial overuse, misuse and abuse.
to minimize the developme
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptxR3 Stem Cell
R3 Stem Cells and Kidney Repair: A New Horizon in Nephrology" explores groundbreaking advancements in the use of R3 stem cells for kidney disease treatment. This insightful piece delves into the potential of these cells to regenerate damaged kidney tissue, offering new hope for patients and reshaping the future of nephrology.
One of the most developed cities of India, the city of Chennai is the capital of Tamilnadu and many people from different parts of India come here to earn their bread and butter. Being a metropolitan, the city is filled with towering building and beaches but the sad part as with almost every Indian city
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfSachin Sharma
This content provides an overview of preventive pediatrics. It defines preventive pediatrics as preventing disease and promoting children's physical, mental, and social well-being to achieve positive health. It discusses antenatal, postnatal, and social preventive pediatrics. It also covers various child health programs like immunization, breastfeeding, ICDS, and the roles of organizations like WHO, UNICEF, and nurses in preventive pediatrics.